SCHEMBL13664477

SCHEMBL13664477

Cc1ccc(C(=O)c2nn(-c3ccc(Cl)cc3)c(NCCCNC(=O)c3ccc4nc(C(F)(F)F)[nH]c4c3)c2C#N)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
LMNA P02545 3/20 0.38
ALDH1A1 P00352 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
HTT P42858 2/20 0.38
MAPT P10636 3/20 0.37
MEN1 O00255 1/20 0.37
THRB P10828 1/20 0.37
CRHBP P24387 1/20 0.37
KMT2A Q03164 1/20 0.37
CRHR2 Q13324 1/20 0.37
F11 P03951 1/20 0.36
KLKB1 P03952 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
KCNH2 Q12809 2/20 0.36
F9 P00740 3/20 0.35
AR P10275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13664417 0.91 ALDH1A1 (0.39) KDM4EALDH1A1L3MBTL1MAPTMEN1
SCHEMBL13664476 0.89 MAPT (0.39) KDM4ELMNAALDH1A1L3MBTL1HTT
SCHEMBL13664381 0.86 L3MBTL1 (0.49) LMNAL3MBTL1HTTMAPTKMT2A
SCHEMBL13664435 0.86 RHOC (0.43) KDM4ELMNAALDH1A1L3MBTL1HTT
SCHEMBL13664448 0.85 POLB (0.38) L3MBTL1MAPTPOLBGAATDP1
SCHEMBL13664385 0.85 L3MBTL1 (0.38) L3MBTL1MAPTPOLBGAATDP1
SCHEMBL13664479 0.85 ACSS2 (0.39) LMNAL3MBTL1HTTMAPTMEN1
SCHEMBL13664143 0.85 POLB (0.46) LMNAL3MBTL1MAPTMEN1KMT2A
SCHEMBL13664373 0.85 POLB (0.46) LMNAL3MBTL1MAPTMEN1KMT2A
SCHEMBL13664437 0.85 RHOC (0.43) KDM4ELMNAALDH1A1L3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-10-08 US disclosed
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists GIPR, GPR119, GLP1R KDM4E 3380/4885LMNA 4188/4885ALDH1A1 3415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.